LAZARD ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$148
+111.4%
15,391
+132.8%
0.00%
Q2 2023$70
+6900.0%
6,612
+5966.1%
0.00%
Q1 2023$1
-99.3%
109
-99.0%
0.00%
Q4 2022$134
-99.9%
10,888
-0.1%
0.00%
Q2 2022$125,000
+60.3%
10,900
+73.8%
0.00%
Q1 2022$78,000
+52.9%
6,270
+59.9%
0.00%
Q3 2021$51,000
-94.2%
3,921
-94.9%
0.00%
-100.0%
Q4 2020$878,000
+136.0%
77,200
+86.6%
0.00%0.0%
Q3 2020$372,000
+332.6%
41,379
+384.8%
0.00%
Q1 2020$86,000
+83.0%
8,536
+138.8%
0.00%
Q4 2019$47,000
+291.7%
3,574
+142.6%
0.00%
Q3 2019$12,0001,4730.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders